Cognitive impairment is common in untreated MS patients, affecting 1 in 4, with rates particularly higher in those with SPMS, ...

Using 3T MRI to analyze central vein counts and distribution in white matter lesions allows investigators to distinguish ...

Scientists at the University of South Australia have come up with an innovative solution to improve the effectiveness of ...

A growing body of research is uncovering connections between aluminium accumulation in the brain and the progression of ...

Christina Applegate, who starred in Netflix’s Dead To Me, was diagnosed with multiple sclerosis in 2021. She shared her ...

Discover how gut bacteria may influence multiple sclerosis progression and severity. Research reveals specific bacterial ...

Kalfus & Nachman is hosting a special event at its Norfolk location to raise funds for MS research, patient care and advocacy ...

which found that the ratio of two types of bacteria in the gut microbiome may be able to predict disease severity in people ...

Dr Annalisa Morgan reflects on incorporating new treatments discussed at the 2025 ACTRIMS Forum into clinical practice.

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...

“We had an idea that maybe B cells from patients with multiple sclerosis are exposed to brain antigens” and that the genetics of those immune cells would be different from those of patients ...